We are live on ! Find out more
MBOT icon

Microbot Medical

28 hedge funds and large institutions have $3.36M invested in Microbot Medical in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more call options, than puts

Call options by funds: $23K | Put options by funds: $8K

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

14% more capital invested

Capital invested by funds: $2.94M → $3.36M (+$420K)

3% less funds holding

Funds holding: 2928 (-1)

7.38% less ownership

Funds ownership: 17.95%10.56% (-7.4%)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
8
Reduced
6
Closed
5
Calls
$23K
Puts
$8K
Net Calls
+$15K
Net Calls Change
+$19K

MBOT Hedge Fund Activity: Q2 2023 in Review

28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2023, worth a combined $3.36M — up 14% from $2.94M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of MBOT and 4 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 8 added.

The largest buyer was Renaissance Technologies, adding an estimated $135K. The largest seller was Armistice Capital, cutting an estimated $430K.

  • 28 institutional investors held Microbot Medical (MBOT) as of Q2 2023, down from 29 in Q1 2023.
  • Funds reported $3.36M of Microbot Medical stock for Q2 2023, up 14% quarter-over-quarter.
  • 4 funds opened new Microbot Medical positions in Q2 2023 and 5 closed out, a net change of -1 holder.
  • The largest Microbot Medical buyer in Q2 2023 was Renaissance Technologies, an estimated $135K added.
  • The largest Microbot Medical seller in Q2 2023 was Armistice Capital, an estimated $430K sold.

Based on aggregated 13F filings for Q2 2023.